Table 1.
Current age (years) [median (IQR)] | 15.4 (12.6–16.8) |
Sex [n (%)] | |
Female | 65 (58) |
Male | 47 (42) |
Ethnicity [n (%)] | |
Black African | 86 (76.8) |
Black other | 13 (11.6) |
Caucasian | 6 (5.4) |
Caucasian, South East Asian | 4 (3.6) |
South Asian | 3 (2.7) |
Current ART therapy [n (%)] | |
On ART | 105 (93.8) |
Not on ART | 7 (6.3) |
First‐line ART [n (%)] | 48 (51.6) |
Other ART [n (%)] | 45 (48.4) |
Age (months) at start of ART [median (IQR)] (n = 93) | 39.8 (5.6–103.4) |
Length of follow‐up from start of ART (months) [median (IQR)] (n = 89) | 128 (59–161) |
CD4:CD8 ratio ≤ 0.4 [n (%)] | 11 (9.8) |
ART, antiretroviral therapy; IQR, interquartile range.